Clinical trial
Autologous Non-cultured Epidermal Cell Suspension Transplantation in the Treatment of Vitiligo
NCT07187882 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Autologous Non-cultured Epidermal Cell Suspension Transplantation in the Treatment of Vitiligo
- Lead sponsor
- Peking University People's Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 25, 2024
- Completion date
- December 31, 2025
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.